HONG KONG, Feb. 19, 2019
/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the
"Company"), China's leading
provider of cord blood collection, laboratory testing,
hematopoietic stem cell processing and stem cell storage
services, today announced that it plans to release its
unaudited financial results for the third quarter and first
nine months of fiscal year 2019 on Monday,
February 25, 2019, after the market close.
The Company will host a conference call at 8:00 a.m. ET on
Tuesday, February 26, 2019 to discuss
its financial performance and provide an overview of the Company's
recent developments, followed by a question and answer session.
Interested parties can access the audio webcast through the
Company's IR website at http://ir.globalcordbloodcorp.com. A replay
of the webcast will be accessible two hours after the conference
call and available for seven days at the same URL as above.
Listeners can also access the call by dialing 1-646-722-4977 or
1-855-824-5644, for US callers, or +852-3027-6500, for Hong Kong callers, access code: 70721948#.
Please dial in ten minutes prior to the conference call to
ensure proper connection, and be prepared to provide your name and
company name to the operator.
Supplemental financial information referenced in the conference
call and the third quarter and first nine months of fiscal
year 2019 earnings press release will be available at
http://www.globalcordbloodcorp.com, in the section titled "Investor
Center/Press Release", after 4:16 p.m. ET on Monday, February 25, 2019, and in the Company's
Report on Form 6-K for the month of February
2019, available on the Securities and Exchange Commission's
website at www.sec.gov.
About Global Cord Blood Corporation
Global Cord Blood Corporation is the first and largest umbilical
cord blood banking operator in China in terms of geographical coverage and
the only cord blood banking operator with
multiple licenses. Under current PRC government regulations,
only one licensed cord blood banking operator is permitted to
operate in each licensed region and no new licenses will be granted
before 2020 in addition to the seven licenses authorized as of
today. Global Cord Blood Corporation provides cord blood
collection, laboratory testing, hematopoietic stem cell processing
and stem cell storage services. For more information, please visit
the Company's website at http://www.globalcordbloodcorp.com.
For more information, please contact:
Global Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@globalcordbloodcorp.com
ICR, Inc.
William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (+1) 646-405-5185
Email: william.zima@icrinc.com
View original
content:http://www.prnewswire.com/news-releases/global-cord-blood-corporation-to-report-third-quarter-and-first-nine-months-fiscal-2019-financial-results-300797123.html
SOURCE Global Cord Blood Corporation